- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
The shareholders of Norilsk Nickel (MCX:GMKN) have approved a dividend for the first nine months of 2014 in the amount of 762.34 rubles per ordinary share.
The shareholders of Norilsk Nickel (MCX:GMKN) have approved a dividend for the first nine months of 2014 in the amount of 762.34 rubles per ordinary share.
As quoted in the press release:
Extraordinary General Meeting of Shareholders of MMC Norilsk Nickel held on December 11 approved dividend payments for 9M 2014 in the amount of RUB 762.34 per ordinary share.
Agenda item concerning related party transaction with CJSC NORMETIMPEX (changes in 25.06.2013 instruction to Commission Agreement dated 21.12.2009) was also approved by the EGM.
Click here for the Norilsk Nickel (MCX:GMKN) press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â